Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Low-Dose PFAS Exposure Alters Cellular Metabolism 
Omics Metabolomics & Lipidomics Mass Spectrometry Environmental

Low-Dose PFAS Exposure Alters Cellular Metabolism 

Cell culture model reveals lipid remodeling and oxidative stress following prolonged PFAS exposure 

03/24/2026 2 min read

Share

A long-term cell culture model combining targeted mass spectrometry and transcriptomics suggests that low-dose exposure to per- and polyfluoroalkyl substances (PFAS) can alter cellular metabolism – even when intracellular accumulation remains minimal. 

In the study, researchers exposed hTERT RPE-1 human epithelial cells to environmentally relevant concentrations of two widely studied PFAS compounds – perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) – over a 24-week period. Intracellular PFAS levels were quantified at multiple time points using a matrix-matched liquid chromatography–tandem mass spectrometry (LC–MS/MS) method with isotopically labeled internal standards. RNA sequencing and lipidomics were then used to examine downstream molecular responses. 

To examine how PFAS levels changed over time, the researchers quantified intracellular concentrations at four points across the exposure period – 24 hours, 7 weeks, 17 weeks, and 24 weeks. Results from this time-course analysis revealed limited intracellular accumulation: PFOS concentrations increased rapidly within the first 24 hours but stabilized thereafter, reaching mean levels of around 0.40 ng per mg of cellular protein. PFOA, by contrast, remained below the method’s limit of detection throughout the study. 

Despite the lack of substantial accumulation, multi-omic analyses revealed clear molecular responses to prolonged exposure. Transcriptomic profiling identified changes associated with oxidative stress pathways and lipid metabolism, while lipidomic measurements indicated shifts consistent with membrane remodeling and altered lipid composition. 

Together, these results suggest that chronic PFAS exposure can trigger adaptive cellular responses even when intracellular concentrations remain low. The authors note that the molecular signatures observed in the study point to coordinated regulation of oxidative stress pathways, lipid metabolism, and membrane dynamics following prolonged exposure. 

They further suggest that PFAS toxicity may not depend on sustained intracellular accumulation, but could instead arise from persistent interactions with cellular membranes and associated stress responses. However, they caution that the simplified in vitro system cannot fully capture the complex toxicokinetics and tissue-specific responses observed in vivo. 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.